Brokerages Set Certara, Inc. (NASDAQ:CERT) Target Price at $20.06

Shares of Certara, Inc. (NASDAQ:CERT) have been given an average rating of “Hold” by the eleven brokerages that are covering the company, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $20.06.

Several analysts have issued reports on the company. Barclays increased their target price on Certara from $16.00 to $18.00 and gave the company an “equal weight” rating in a research report on Thursday, January 25th. UBS Group upped their price target on Certara from $17.00 to $20.00 and gave the stock a “neutral” rating in a research report on Friday, March 1st. Leerink Partnrs reaffirmed a “market perform” rating on shares of Certara in a research report on Monday, February 26th. SVB Leerink started coverage on Certara in a research note on Monday, February 26th. They set a “market perform” rating and a $19.00 price target on the stock. Finally, KeyCorp upgraded shares of Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 target price for the company in a research note on Wednesday, April 10th.

Insider Activity at Certara

In other news, SVP Richard M. Traynor sold 3,000 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $18.00, for a total transaction of $54,000.00. Following the sale, the senior vice president now directly owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, SVP Richard M. Traynor sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the transaction, the senior vice president now directly owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Patrick F. Smith sold 14,427 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total value of $243,094.95. Following the transaction, the insider now owns 50,091 shares in the company, valued at approximately $844,033.35. The disclosure for this sale can be found here. Insiders sold a total of 23,427 shares of company stock worth $405,095 in the last three months. Company insiders own 2.60% of the company’s stock.

Institutional Trading of Certara

Several institutional investors have recently modified their holdings of CERT. Vontobel Holding Ltd. boosted its stake in shares of Certara by 12.5% in the third quarter. Vontobel Holding Ltd. now owns 27,921 shares of the company’s stock worth $406,000 after acquiring an additional 3,111 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Certara by 193.3% in the third quarter. SG Americas Securities LLC now owns 20,047 shares of the company’s stock valued at $291,000 after buying an additional 13,213 shares during the last quarter. Commonwealth Equity Services LLC boosted its position in Certara by 31.2% during the third quarter. Commonwealth Equity Services LLC now owns 19,055 shares of the company’s stock worth $277,000 after acquiring an additional 4,528 shares during the last quarter. NorthRock Partners LLC purchased a new position in Certara in the 3rd quarter worth approximately $168,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Certara by 16.9% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,117 shares of the company’s stock worth $351,000 after purchasing an additional 3,482 shares during the last quarter. Institutional investors and hedge funds own 73.96% of the company’s stock.

Certara Stock Up 1.7 %

Shares of NASDAQ CERT opened at $16.57 on Thursday. The stock has a 50 day moving average price of $17.69 and a 200 day moving average price of $16.25. The firm has a market capitalization of $2.65 billion, a price-to-earnings ratio of -47.34, a PEG ratio of 1.68 and a beta of 1.63. Certara has a 52-week low of $11.81 and a 52-week high of $24.64. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.62 and a current ratio of 2.62.

Certara (NASDAQ:CERT) last announced its quarterly earnings results on Thursday, February 29th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). Certara had a negative net margin of 15.62% and a positive return on equity of 4.33%. The firm had revenue of $88.01 million for the quarter, compared to analysts’ expectations of $86.80 million. Sell-side analysts expect that Certara will post 0.29 earnings per share for the current year.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.